My Member
Message Center
trending topics
market reports
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
Zimbabwe buoyed by Chinese jabs
2021-12-31
Chinese researchers develop new diagnostic method for ovarian cancer
2020-08-20
Chinese researchers have developed a non-invasive method to differentiate ovarian cancer subtypes, which could help improve therapeutic plans, according to the Chinese Academy of Sciences (CAS).
Ovarian cancers can be divided into type I and type II according to etiology and prognosis. Accurate subtype differentiation can help improve treatment plans and prognosis.
Researchers from the Suzhou Institute of Biomedical Engineering and Technology under the CAS and Jinshan Hospital of Fudan University conducted a multicenter study involving more than 294 ovarian cancer patients, of which 143 were type I and 151 type II.
They collected the Magnetic Resonance Imaging (MRI) of patients and used machine learning method to build a novel MRI-based radiomics model that can differentiate between type I and type II ovarian cancer. The diagnosis has an average accuracy of 83 percent.
The research was published in the journal European Radiology.
(People's Daily)
